Stay updated on Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    An NIH sitewide notice appears above the 403 error page, linking to transition updates and stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T13:12:28.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-18T14:46:47.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now shows revision v3.7.1 instead of v3.7.0; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:59:49.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the study record is temporarily inaccessible.
    Difference
    23%
    Check dated 2026-09-20T22:26:18.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6 instead of v3.6.5, signaling a new version of the page has been published. This is a minor update to page metadata and does not indicate a substantive change to the study content.
    Difference
    0.0%
    Check dated 2026-08-30T22:19:27.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing v3.6.4. This signals a minor internal version update to the page’s content or configuration.
    Difference
    0.0%
    Check dated 2026-08-09T11:18:57.000Z thumbnail image

Stay in the know with updates to Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ibrutinib+Bendamustine/Rituximab in Mantle Cell Lymphoma Clinical Trial page.